Sana Biotechnology Inc (SANA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SANA Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Sana Biotechnology Inc.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/SANA/balance-sheets
https://api.csimarket.com/api/v1/companies/SANA/fundamentals
https://api.csimarket.com/api/v1/companies/SANA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent41.10
Combined Cash+Investments Total (filer-reported)121.70
Restricted Cash7.56
Marketable Securities, Current SH80.62
Short-term Investments0.00
Cash & Short-term Investments121.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current6.82
Total Current Assets132.31
Equipment/Property/Plant Net85.14
Goodwill net140.63
Intangible Assets59.20
Intangible AssetsAnd Goodwill0.00
Restricted Cash Current4.20
Operating Lease Right Of Use Asset35.85
Total Assets376.13
Liabilities
Accounts Payable, Current AC1.95
Employee-related Liabilities, Current AC10.65
Other Liabilities, Current21.63
Business Combination, Contingent Consideration, Liability, Current BU40.65
Total Current Liabilities74.88
Total Long-term Debt0.00
Other liabilities, Noncurrent120.88
Operating Lease Liability Current14.88
Operating Lease Liability Noncurrent60.45
Success Payment Liabilities Noncurrent16.93
Total Liabilities195.76
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock2,119.90
Retained Earnings / Accumulated Deficit-1,939.46
Accumulated Other Comprehensive Income-0.10
Other Equity-0.10
Common Stockholder's Equity180.36
Total Stockholder's Equity180.36
Liabilities & Stockholder's Equity376.13
4 historic quarters locked

Sign in to unlock the full Sana Biotechnology Inc balance sheet history.

About Sana Biotechnology Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-449836

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI